“…Further transcriptome analysis revealed that alkaloid content was highly correlated with the expression of six genes involved in alkaloid biosynthesis, including DHS ( Dca021396 ), DoADH ( Dca025688 ), DoTYDC ( Dca021379 ), and DoTR ( Dca000522 , Dca027425 , and Dca000521 ), as well as seven genes related to jasmonate biosynthesis, including DoLOX ( Dca023278 ), DoAOS ( Dca022684 ), and DoOPR ( newGene_9791 , newGene_13686 , Dca023268 , Dca001807 , and Dca000910 ), which may play important roles in the alkaloid biosynthesis of D. officinale . Weighted gene coexpression network analysis also identified 66 transcription factors, mainly belonging to the AP2/ERF, MYB, bHLH, WRKY, bZIP, and Tify families, that were positively correlated with alkaloid content, as well as transcription factors involved in the regulation of TIAs and isoquinoline alkaloid biosynthesis, including DoFPS ( Dca007721 ), DoDHQS ( Dca008449 ), DoDHS ( Dca021396 and Dca004228 ), DoCS ( Dca015447 ), DoCM ( Dca012195 ), DoTYDC ( Dca021379 ), DoADH ( Dca025688 ), DoTR ( Dca027425 ), DoAOS ( Dca022684 and Dca000659 ), and DoOPR ( Dca023268 ) . Another study suggested that the alkaloid content in D. officinale samples treated with MeJA was highest at 32 days (343 μg/g), consistent with previous studies .…”